VKVicki L. Kramer

Vicki L. Kramer

*This is an algorithmically generated author record based on publicly available information.

Vicki L. Kramer has a total of 18 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A forty-year review of Rocky Mountain spotted fever cases in California shows clinical and epidemiologic changes

    by Anne M. Kjemtrup, Kerry Padgett, Christopher D. Paddock, Sharon Messenger, Jill K. Hacker, Tina Feiszli, Michael Melgar, Marco E. Metzger, Renjie Hu, Vicki L. Kramer

    Rocky Mountain spotted fever (RMSF) is a life-threatening tick-borne disease documented in North, Central, and South America. In California, RMSF is rare; nonetheless, recent fatal cases highlight ecological cycles of the two genera of ticks,DermacentorandRhipicephalus, known to transmit the disease. These ticks occur in completely different habitats (sylvatic and peridomestic, respectively) resulting in different exposure risks for humans. This study summarizes the demographic, exposure, and clinical aspects associated with the last 40 years of reported RMSF cases to the California Department of Public Health (CDPH). Seventy-eight RMSF cases with onsets from 1980 to 2019 were reviewed. The incidence of RMSF has risen in the last 20 years from 0.04 cases per million to 0.07 cases per million (a two-fold increase in reports), though the percentage of cases that were confirmed dropped significantly from 72% to 25% of all reported cases. Notably, Hispanic/Latino populations saw the greatest rise in incidence. Cases of RMSF in California result from autochthonous and out-of-state exposures. During the last 20 years, more cases reported exposure in Southern California or Mexico than in the previous 20 years. The driver of these epidemiologic changes is likely the establishment and expansion ofRhipicephalus sanguineussensu lato ticks in Southern California and on-going outbreaks of RMSF in northern Mexico. Analysis of available electronically reported clinical data from 2011 to 2019 showed that 57% of reported cases presented with serious illness requiring hospitalization with a 7% mortality. The difficulty in recognizing RMSF is due to a non-specific clinical presentation; however, querying patients on the potential of tick exposure in both sylvatic and peridomestic environments may facilitate appropriate testing and treatment.


  • Open Access

    Evaluation of the effectiveness of the California mosquito-borne virus surveillance & response plan, 2009–2018

    by Mary E. Danforth, Robert E. Snyder, Emma T. N. Lonstrup, Christopher M. Barker, Vicki L. Kramer

    Local vector control and public health agencies in California use the California Mosquito-Borne Virus Surveillance and Response Plan to monitor and evaluate West Nile virus (WNV) activity and guide responses to reduce the burden of WNV disease. All available data from environmental surveillance, such as the abundance and WNV infection rates in Culex tarsalis and the Culex pipiens complex mosquitoes, the numbers of dead birds, seroconversions in sentinel chickens, and ambient air temperatures, are fed into a formula to estimate the risk level and associated risk of human infections. In many other areas of the US, the vector index, based only on vector mosquito abundance and infection rates, is used by vector control programs to estimate the risk of human WNV transmission. We built models to determine the association between risk level and the number of reported symptomatic human disease cases with onset in the following three weeks to identify the essential components of the risk level and to compare California’s risk estimates to vector index. Risk level calculations based on Cx. tarsalis and Cx. pipiens complex levels were significantly associated with increased human risk, particularly when accounting for vector control area and population, and were better predictors than using vector index. Including all potential environmental components created an effective tool to estimate the risk of WNV transmission to humans in California.


  • Open Access

    West Nile virus in California, 2003–2018: A persistent threat

    by Robert E. Snyder, Tina Feiszli, Leslie Foss, Sharon Messenger, Ying Fang, Christopher M. Barker, William K. Reisen, Duc J. Vugia, Kerry A. Padgett, Vicki L. Kramer

    The California Arbovirus Surveillance Program was initiated over 50 years ago to track endemic encephalitides and was enhanced in 2000 to include West Nile virus (WNV) infections in humans, mosquitoes, sentinel chickens, dead birds and horses. This comprehensive statewide program is a function of strong partnerships among the California Department of Public Health (CDPH), the University of California, and local vector control and public health agencies. This manuscript summarizes WNV surveillance data in California since WNV was first detected in 2003 in southern California. From 2003 through 2018, 6,909 human cases of WNV disease, inclusive of 326 deaths, were reported to CDPH, as well as 730 asymptomatic WNV infections identified during screening of blood and organ donors. Of these, 4,073 (59.0%) were reported as West Nile neuroinvasive disease. California’s WNV disease burden comprised 15% of all cases that were reported to the U.S. Centers for Disease Control and Prevention during this time, more than any other state. Additionally, 1,299 equine WNV cases were identified, along with detections of WNV in 23,322 dead birds, 31,695 mosquito pools, and 7,340 sentinel chickens. Annual enzootic detection of WNV typically preceded detection in humans and prompted enhanced intervention to reduce the risk of WNV transmission. Peak WNV activity occurred from July through October in the Central Valley and southern California. Less than five percent of WNV activity occurred in other regions of the state or outside of this time. WNV continues to be a major threat to public and wild avian health in California, particularly in southern California and the Central Valley during summer and early fall months. Local and state public health partners must continue statewide human and mosquito surveillance and facilitate effective mosquito control and bite prevention measures.


  • Efficacy and Persistence of Bacillus sphaericus, Bacillus thuringiensis var. israelensis, and Methoprene Against Culiseta incidens (Diptera: Culicidae) in Tires

    by Vicki L. Kramer

    The efficacy and persistence of Bacillus sphaericus (2362) was compared at three dosage rates in tires that continually contained cadavers of Culiseta incidens (Thomson) versus tires with all dead larvae removed. At treatment rates of 3.75 and 7.5 ppm, the continual presence of cadavers in the tire water resulted in higher mortality rates. At the 15 ppm treatment rate, mortality rates were similar in tires with or without cadavers. Mortality rates increased in all tires 4-6 wk after treatment, suggesting an amplification of the pathogen. The mortality rate did not exceed 90% for >2 wk in any of the tires. At a second site, the efficacy of B. sphaericus, Bacillus thuringiensis var. israelensis, and methoprene was evaluated against C. incidens in tires exposed to full sunlight versus shaded tires. In shaded tires inoculated with B. sphaericus (15 ppm) and B. thuringiensis var. israelensis (15 ppm), mortality exceeded 90% for 5 and 2 wk, and 50% for 10 and 4 wk, for the two bacteria, respectively. Larvae were adequately controlled (>75% mortality) in the sunny tires for ≈1 wk. The insect growth regulator, methoprene (applied at 2.5 ppm), inhibited the emergence of ≈90% of the larvae present at the time of treatment, but not of larvae subsequently introduced into either the sunny or shaded tires.